Arcutis Biotherapeutics, Inc. officer Patrick Burnett filed a Form 144 notice of proposed sale of securities on November 2, 2026, disclosing plans to sell 943 shares of common stock on NASDAQ.
Kristine Syrvalin, an officer of Metallus Inc., filed a Form 144 notice of proposed sale of securities on November 2, 2026, covering 9,092 shares of common stock with an aggregate market value of $200,024.
Director Eugene Nonko filed a Form 144 notice of proposed sale with the SEC on November 2, 2026, disclosing plans to sell 632,572 shares of MediaAlpha, Inc. common stock on NYSE:MAX through Charles Schwab & Co., Inc.
Diversified Healthcare Trust filed its quarterly report on Form 10-Q with the SEC on November 2, 2026, covering the period ended September 30, 2026, disclosing a net loss of $50,229 thousand for the third quarter and total revenues of $367,670 thousand.
Steven Yi, an officer and director of MediaAlpha, Inc., filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 398,033 shares of MediaAlpha common stock through Charles Schwab & Co., Inc.
Kevin Raketich, an officer of Metallus Inc., filed a Form 144 notice on November 2, 2026, proposing the sale of 22,800 shares of Metallus common stock through a Rule 10b5-1 trading plan adopted on May 12, 2026.
Todd Franklin Watanabe, an officer of Arcutis Biotherapeutics, Inc., filed a Form 144 notice on November 2, 2026, proposing the sale of 4,377 shares of common stock on NASDAQ.
Boston Scientific Corporation filed its quarterly report on Form 10-Q with the SEC on November 2, 2026, covering the three and nine months ended September 30, 2026, and reporting net sales of $5.138 billion for the third quarter.
i-80 Gold Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the U.S. Securities and Exchange Commission on November 2, 2026, disclosing share count, operational developments, and forward-looking guidance related to its Nevada gold mining assets.
Roper Technologies, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 2, 2026, reporting third-quarter net revenues of $2,171.8 million and diluted earnings per share of $4.88.